Yahoo
OTC Markets OTCPK - Delayed Quote USD

Grey Matters Health Inc. (AGNPF)

0.2403 -0.0255 (-9.60%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for AGNPF
  • Previous Close 0.2657
  • Open 0.2380
  • Bid 0.2200 x 2000000
  • Ask 0.2635 x 1500000
  • Day's Range 0.2380 - 0.2380
  • 52 Week Range 0.2183 - 0.6400
  • Volume 5,000
  • Avg. Volume 4,826
  • Market Cap (intraday) 2.315M
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3600
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada, the United States, and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

www.greymatters-health.com

--

Full Time Employees

August 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

AGNPF
56.75%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

AGNPF
62.46%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

AGNPF
49.95%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

AGNPF
98.18%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY23
Revenue --
Earnings --
Profit Margin 0.00%

Q3

FY22

Q4

FY22

Q1

FY23

Q2

FY23

0
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.51%

  • Return on Equity (ttm)

    -124.73%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.18M

  • Diluted EPS (ttm)

    -0.3600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    41.66k

  • Total Debt/Equity (mrq)

    44.44%

  • Levered Free Cash Flow (ttm)

    -1.38M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: